Producing striatal phenotypes for transplantation in Huntington's disease

Precious, Sophie Victoria and Rosser, Anne Elizabeth ORCID: https://orcid.org/0000-0002-4716-4753 2012. Producing striatal phenotypes for transplantation in Huntington's disease. Experimental Biology and Medicine 237 (4) , pp. 343-351. 10.1258/ebm.2011.011359

Full text not available from this repository.

Abstract

Neural transplantation as a therapeutic strategy in neurodegenerative disorders offers to replace cells lost during the disease process, with the potential to reconstruct dysfunctional circuitry, thus alleviating associated disease symptoms. The focal loss of striatal cells, specifically medium-sized spiny neurons (MSN) in Huntington's disease (HD), makes transplantation a therapeutic option. Here, we review the progress made in generating striatal MSN phenotypes for transplantation in HD. We discuss the use of primary fetal tissue as a donor source in both preclinical and clinical studies and assess the options for renewable cell sources. We evaluate progress in directing the differentiation of renewable cells towards a striatal MSN phenotype for HD.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Biosciences MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine Neuroscience and Mental Health Research Institute (NMHRI)
Subjects:	R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords:	Huntington's disease; medium-sized spiny neurons; neural transplantation; primary fetal tissue; embryonic stem cells
Publisher:	The Society of Experimental Biology and Medicine
ISSN:	1535-3702
Last Modified:	21 Oct 2022 10:55
URI:	https://orca.cardiff.ac.uk/id/eprint/41732

Citation Data

Cited 14 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item